Bluespine
Latest round
- Seed
Last raised
- Nov 2024
Total raised
- $7.2M
Investors
- 1
About Bluespine
Based in New York, US, and founded in 2023 by co-founders David Talinovsky (CEO) and Gal Frishman (CTO), Bluespine, Inc. operates a provider of a claims review platform intended to prevent financial losses from healthcare overbilling. In November 2024, Bluespine, Inc. The company offers a claims review platform designed to prevent financial leakage due to medical overbilling. The core product leverages artificial intelligence (AI) to conduct detailed reviews of healthcare claims, ensuring that every potential savings opportunity is identified and recovered. Bluespine’s technology tailors its analysis based on the specific terms of individual plan contracts, allowing for customized rule sets that enhance accuracy in pinpointing errors. The platform serves a diverse client base, including employers, third-party administrators (TPAs), brokers, and auditors, who utilize Bluespine to optimize healthcare cost management and fulfill fiduciary obligations. The company's services are primarily aimed at the employer-sponsored health insurance market, with a focus on improving cost efficiency and compliance across various geographical markets, including the United States. Bluespine's revenue model is structured around a performance-based pricing system, wherein the company charges fees only when it successfully saves clients money on their healthcare expenses. This aligns the company's financial interests with those of its clients, fostering a mutually beneficial relationship. Transactions typically occur through business-to-business (B2B) partnerships, where employers and other stakeholders engage Bluespine to leverage its AI-driven capabilities in claims analysis. Future initiatives include the development of new features for their claims review platform aimed at enhancing user experience and increasing the efficiency of the claims analysis process. Bluespine plans to expand its operations into additional markets across the US by the end of 2025, targeting states with high healthcare spending.
Who invested in Bluespine
1 investor across 1 round
See all investors in Bluespine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 13, 2024
Amount
$7.2M
Investors
Questions about Bluespine
Who invested in Bluespine?
Bluespine has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bluespine raised?
Bluespine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bluespine last raise money?
Bluespine's most recent round on record is a Seed, in Nov 2024.
What does Bluespine do?
Based in New York, US, and founded in 2023 by co-founders David Talinovsky (CEO) and Gal Frishman (CTO), Bluespine, Inc.
Where is Bluespine headquartered?
Bluespine is headquartered in New York, US.
Which VCs invest in companies like Bluespine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Bluespine's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Bluespine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.